BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21398516)

  • 1. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
    Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
    J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.
    Dery KJ; Silver C; Yang L; Shively JE
    J Biol Chem; 2018 Jun; 293(24):9277-9291. PubMed ID: 29720400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hnRNP L and hnRNP A1 induce extended U1 snRNA interactions with an exon to repress spliceosome assembly.
    Chiou NT; Shankarling G; Lynch KW
    Mol Cell; 2013 Mar; 49(5):972-82. PubMed ID: 23394998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene.
    Oh Hk; Lee E; Jang HN; Lee J; Moon H; Sheng Z; Jun Y; Loh TJ; Cho S; Zhou J; Green MR; Zheng X; Shen H
    Apoptosis; 2013 Jul; 18(7):825-35. PubMed ID: 23430061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
    Gaur S; Shively JE; Yen Y; Gaur RK
    Mol Cancer; 2008 May; 7():46. PubMed ID: 18507857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous ribonucleoprotein m is a splicing regulatory protein that can enhance or silence splicing of alternatively spliced exons.
    Hovhannisyan RH; Carstens RP
    J Biol Chem; 2007 Dec; 282(50):36265-74. PubMed ID: 17959601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA.
    Park E; Iaccarino C; Lee J; Kwon I; Baik SM; Kim M; Seong JY; Son GH; Borrelli E; Kim K
    J Biol Chem; 2011 Jul; 286(28):25301-8. PubMed ID: 21622564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP A1 and secondary structure coordinate alternative splicing of Mag.
    Zearfoss NR; Johnson ES; Ryder SP
    RNA; 2013 Jul; 19(7):948-57. PubMed ID: 23704325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneous nuclear ribonucleoprotein L is an essential component in the Ca2+/calmodulin-dependent protein kinase IV-regulated alternative splicing through cytidine-adenosine repeats.
    Yu J; Hai Y; Liu G; Fang T; Kung SK; Xie J
    J Biol Chem; 2009 Jan; 284(3):1505-13. PubMed ID: 19017650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
    Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
    BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping.
    Zhang B; Xie SH; Hu JY; Lei SJ; Shen LH; Liu HT; Zheng Q; Zhang ZM; Wu CL; Li Q; Wang F
    Acta Pharmacol Sin; 2023 Nov; 44(11):2307-2321. PubMed ID: 37402999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HnRNP L-mediated regulation of mammalian alternative splicing by interference with splice site recognition.
    Heiner M; Hui J; Schreiner S; Hung LH; Bindereif A
    RNA Biol; 2010; 7(1):56-64. PubMed ID: 19946215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor.
    Hutchison S; LeBel C; Blanchette M; Chabot B
    J Biol Chem; 2002 Aug; 277(33):29745-52. PubMed ID: 12060656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    Tange TO; Damgaard CK; Guth S; Valcárcel J; Kjems J
    EMBO J; 2001 Oct; 20(20):5748-58. PubMed ID: 11598017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
    Chabot B; Blanchette M; Lapierre I; La Branche H
    Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.